Placental 11β-Hydroxysteroid dehydrogenase type 2 expression: Correlations with birth weight and placental metal

C Mikelson1, M J Kovach1, J Troisi2

  • 1Department of Biological and Environmental Sciences, University of Tennessee-Chattanooga, 615 McCallie Ave., Chattanooga, TN 37403, USA.

Placenta
|October 15, 2015
PubMed

Insights

Placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) expression correlates with fetal growth. Maternal trace metal status influences this placental enzyme, impacting fetal development.

Area of Science:

  • Reproductive Biology
  • Developmental Biology
  • Environmental Health

Background:

  • Low birth weight (LBW) is associated with adverse outcomes.
  • Excess fetal cortisol exposure can restrict growth.
  • Placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) protects the fetus by inactivating cortisol.

Purpose of the Study:

  • To investigate the correlation between placental 11β-HSD2 expression and fetal birth weight.
  • To examine the relationship between placental metal concentrations and 11β-HSD2 expression.

Main Methods:

  • Placental samples from 191 births were analyzed for 11β-HSD2 mRNA expression using qRT-PCR.
  • Metal concentrations (18 elements) were quantified in placental tissue from 160 births using ICP-MS.
  • Statistical analyses correlated 11β-HSD2 expression with birth weight parameters and metal levels.

Main Results:

  • 11β-HSD2 expression positively correlated with birth weight centile and actual birth weight.
  • Maternal age and gestational age showed a positive correlation.
  • Four metals (Cobalt, Manganese, Nickel, Zinc) positively correlated with 11β-HSD2 expression.
  • Sex-specific correlations were observed for several metals (Co, Cu, Fe, Zn, Ni) in male placentas.

Conclusions:

  • Fetal growth potential is linked to placental 11β-HSD2 expression.
  • Maternal trace metal status influences placental 11β-HSD2 expression, affecting fetal development.
Abstract